Physico-chemical stability of co-formulation of PEGylated human amylin with insulin
Sign Up to like & getrecommendations! Published in 2019 at "Pharmaceutical Development and Technology"
DOI: 10.1080/10837450.2019.1621896
Abstract: Abstract Since the discovery of amylin no combined formulation with insulin has been made available. Amylin or its triple proline analog pramlintide are not compatible in solution with insulin. The drug candidate hAmy-PEG5k is a… read more here.
Keywords: insulin; hamy peg5k; glargine detemir; human amylin ... See more keywords